Interstitial lung diseases (ILDs) comprise a heterogeneous group of disorders (such as
idiopathic pulmonary fibrosis, sarcoidosis, asbestosis, and pneumonitis) characterized by …

High-flow nasal cannula (HFNC) has recently emerged as a crucial therapeutic strategy for
hypoxemic patients both in acute and chronic settings. Indeed, HFNC therapy is able to …

ABSTRACT Introduction Long-term High Flow Nasal Cannula (LT-HFNC), defined as High
Flow Nasal Cannula treatment provided to patients with chronic pulmonary conditions …

Background and objective Exercise capacity in idiopathic pulmonary fibrosis (IPF) is limited
by exercise‐induced hypoxaemia. This study aimed to examine the effect of high‐flow nasal …

Abstract Background and Objective Interstitial lung disease (ILD) is characterized by
dyspnoea on exertion and exercise‐induced hypoxaemia. High‐flow nasal cannula (HFNC) …

Introduction Interstitial Lung Diseases (ILD) affect the lung parenchyma and are often
complicated by respiratory failure (RF) and impaired physical activity. High Flow Nasal …

Abstract This Thoracic Society of Australia and New Zealand Guideline on the provision of
home oxygen therapy in adults updates a previous Guideline from 2015. The Guideline is …

Background Supplemental oxygen delivered with standard oxygen therapy (SOT) improves
exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). Although high-flow …

Exercise increases the cost of breathing (COB) due to increased lung ventilation (V˙ E),
inducing respiratory muscles deoxygenation (∇ SmO2), while the increase in workload …

Objective The aims were twofold:(a) to map tools documented in the literature to evaluate
comfort among patients undergoing high flow nasal cannula (HFNC) treatment; and (b) to …